Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma
Launched by ERASMUS MEDICAL CENTER · Sep 23, 2024
Trial Information
Current as of May 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way for patients who have had surgery for colorectal cancer to monitor their health from home. The main goal is to help improve their quality of life and reduce stress, while also keeping a close eye on their health. Participants will do simple assessments at home, which include having their blood tested for a specific cancer marker, filling out questionnaires about their mental and physical well-being, and using a smart sensor to check important health measurements.
To join the trial, patients need to be at least 21 years old and have been treated for colorectal cancer with surgery less than six months ago. They should also have access to a smartphone and be able to understand and complete the questionnaires. This study is currently looking for participants, and it offers a flexible and supportive approach to follow-up care. If you or a loved one are eligible, this could be a great opportunity to help improve how patients manage their recovery after surgery.
Gender
ALL
Eligibility criteria
- • inclusion criteria
- • Age ≥ 21 years
- • Histologically confirmed colorectal adenocarcinoma without distant metastasis and treated with curative intent surgical resection less than 6 months ago
- • Scheduled or currently undergoing postoperative surveillance according to national guidelines
- • Written informed consent by the patient
- • Access to a smartphone
- • Exclusion criteria
- • Patients with a severely complicated postoperative course, needing in hospital follow- up longer than 6 months postoperatively
- • Patients enrolled in other studies that require strict adherence to any specific follow-up practice with regular imaging - yearly or more frequent - of the abdomen and/or thorax
- • Patients with comorbidity or other malignancy that requires imaging of the abdomen and/or thorax every year or more frequent
- • Patients with active implantable devices - e.g. pacemaker or implantable defibrillator
- • Inability to complete the questionnaires due to illiteracy and/or insufficient proficiency of the Dutch language
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, Zuid Holland, Netherlands
Breda, Brabant, Netherlands
Rotterdam, Zuid Holland, Netherlands
Capelle Aan Den Ijssel, Zuid Holland, Netherlands
Rotterdam, Zuid Holland, Netherlands
Patients applied
Trial Officials
Dirk J. Grunhagen, MD, PhD
Principal Investigator
Erasmus Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported